Valuation: Aoxing Pharmaceutical Company, Inc.

Market Cap 23.62M 20.65M 19.05M 17.56M 33.1M 2.28B 33.83M 228M 89.56M 1.11B 88.72M 86.78M 3.84B P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 42.18M 36.87M 34.02M 31.36M 59.1M 4.06B 60.41M 407M 160M 1.99B 158M 155M 6.85B EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
05/08/17 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
16/05/17 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
14/02/17 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
14/11/16 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
05/10/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16/05/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
08/02/16 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
01/02/16 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
10/12/15 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
04/12/15 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
02/12/15 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
13/11/15 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
13/10/15 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
1 day-2.78%
1 week-2.78%
Current month-14.63%
1 month-32.69%
3 months-16.67%
6 months-14.63%
Current year+6.06%
1 week 0
Extreme 0.0035
0
1 month 0
Extreme 0.0035
0
Current year 0
Extreme 0.0016
0.01
1 year 0
Extreme 0.0016
0.01
3 years 0
Extreme 0.0011
0.02
5 years 0
Extreme 0
0.02
10 years 0
Extreme 0
0.83
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
-2.78%-2.78%-46.97%+133.33% 1.33M
-2.29%-17.98%+22.16%+476.78% 2.23B
-3.47%-3.32% - - 1.96B
-2.72%-4.79%-41.31%-62.08% 1.68B
-2.30%-20.29%+88.14%+586.27% 1.4B
-0.46%+2.14%-39.27%+38.26% 1.22B
+0.49%+0.24%+311.20%+921.00% 1.1B
-0.75%-0.02%+48.03%+28.46% 939M
+10.06%-15.46%+34.48%+43.98% 706M
-2.22%-4.76%-41.95%-90.23% 438M
Average -0.65%-4.30%+37.17%+230.64% 1.17B
Weighted average by Cap. -1.24%-5.73%+46.31%+294.54%

Financials

2015 2016
Net sales 25.48M 22.27M 20.55M 18.94M 35.7M 2.45B 36.49M 246M 96.6M 1.2B 95.69M 93.59M 4.14B 32.33M 28.25M 26.07M 24.03M 45.29M 3.11B 46.3M 312M 123M 1.52B 121M 119M 5.25B
Net income 5.49M 4.8M 4.43M 4.08M 7.7M 529M 7.87M 52.96M 20.83M 259M 20.64M 20.18M 892M 2.06M 1.8M 1.66M 1.53M 2.89M 198M 2.95M 19.87M 7.81M 97.22M 7.74M 7.57M 335M
Net Debt 24.8M 21.68M 20M 18.44M 34.75M 2.39B 35.52M 239M 94.04M 1.17B 93.15M 91.11M 4.03B 18.56M 16.22M 14.97M 13.8M 26M 1.79B 26.58M 179M 70.36M 875M 69.7M 68.17M 3.01B
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
346
Date Price Change Volume
13/07/26 $0.003500 -2.78% 46,020
10/07/26 $0.003600 0.00% 14,270
  1. Stock Market
  2. Stocks
  3. AOXG Stock